Potential therapeutic role of budesonide to reduce COVID-19 severity
J Infect Public Health
.
2022 Jan;15(1):109-111.
doi: 10.1016/j.jiph.2021.11.003.
Epub 2021 Nov 12.
Authors
Md Mohiuddin
1
,
Kazuo Kasahara
2
Affiliations
1
Department of Respiratory Medicine, Kanazawa University, Ishikawa, Japan. Electronic address: mohiuddin@med.kanazawa-u.ac.jp.
2
Department of Respiratory Medicine, Kanazawa University, Ishikawa, Japan.
PMID:
34802976
PMCID:
PMC8585565
DOI:
10.1016/j.jiph.2021.11.003
No abstract available
Publication types
Editorial
MeSH terms
Budesonide*
COVID-19*
Glucocorticoids
Humans
SARS-CoV-2
Substances
Glucocorticoids
Budesonide